Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up

Malignant melanoma is a serious disease in both humans and dogs, and the high metastatic potential results in poor prognosis for many patients. Its similarities with human melanoma make spontaneous canine melanoma an excellent model for comparative studies of novel therapies and tumor biology. Gene...

Full description

Bibliographic Details
Main Authors: Sara Saellstrom, Arian Sadeghi, Emma Eriksson, Thomas Segall, Maria Dimopoulou, Olle Korsgren, Angelica SI. Loskog, Thomas H. Tötterman, Akseli Hemminki, Henrik Ronnberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Veterinary Science
Subjects:
immuno oncology
adenoviral vectors
translational medicine
canine malignant melanoma
clinical trials
AdCD40L
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2021.695222/full

Internet

https://www.frontiersin.org/articles/10.3389/fvets.2021.695222/full

Similar Items